282 related articles for article (PubMed ID: 8220906)
1. Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2.
Miyake A; Yamamoto H; Kubota E; Hamaguchi K; Kouda A; Honda K; Kawashima H
Br J Pharmacol; 1993 Sep; 110(1):447-53. PubMed ID: 8220906
[TBL] [Abstract][Full Text] [Related]
2. The novel natural product YM-26567-1 [(+)-trans-4-(3-dodecanoyl-2,4,6- trihydroxyphenyl)-7-hydroxy-2-(4-hydroxyphenyl)chroman]: a competitive inhibitor of group II phospholipase A2.
Miyake A; Yamamoto H; Takebayashi Y; Imai H; Honda K
J Pharmacol Exp Ther; 1992 Dec; 263(3):1302-7. PubMed ID: 1469636
[TBL] [Abstract][Full Text] [Related]
3. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.
Kim K; Jung SY; Lee DK; Jung JK; Park JK; Kim DK; Lee CH
Biochem Pharmacol; 1998 Apr; 55(7):975-85. PubMed ID: 9605421
[TBL] [Abstract][Full Text] [Related]
4. Antiinflammatory action of thielocin A1 beta, a group II phospholipase A2 specific inhibitor, in rat carrageenan-induced pleurisy.
Tanaka K; Kato T; Matsumoto K; Yoshida T
Inflammation; 1993 Apr; 17(2):107-19. PubMed ID: 8491510
[TBL] [Abstract][Full Text] [Related]
5. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
[TBL] [Abstract][Full Text] [Related]
6. Exogenous group II phospholipase A2 induces prostaglandin E2 production in mouse peritoneal macrophages.
Miyake A; Yamamoto H; Enomori T; Kawashima H
Eur J Pharmacol; 1994 Feb; 253(1-2):155-61. PubMed ID: 8013541
[TBL] [Abstract][Full Text] [Related]
7. Induction of distinct sets of secretory phospholipase A(2) in rodents during inflammation.
Hamaguchi K; Kuwata H; Yoshihara K; Masuda S; Shimbara S; Oh-ishi S; Murakami M; Kudo I
Biochim Biophys Acta; 2003 Nov; 1635(1):37-47. PubMed ID: 14642775
[TBL] [Abstract][Full Text] [Related]
8. Effects of phycocyanin extract on prostaglandin E2 levels in mouse ear inflammation test.
Romay C; Ledón N; González R
Arzneimittelforschung; 2000 Dec; 50(12):1106-9. PubMed ID: 11190776
[TBL] [Abstract][Full Text] [Related]
9. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.
Landucci EC; Antunes E; Donato JL; Faro R; Hyslop S; Marangoni S; Oliveira B; Cirino G; de Nucci G
Br J Pharmacol; 1995 Feb; 114(3):578-83. PubMed ID: 7537590
[TBL] [Abstract][Full Text] [Related]
11. Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice.
Ferrándiz ML; Gil B; Sanz MJ; Ubeda A; Erazo S; González E; Negrete R; Pacheco S; Payá M; Alcaraz MJ
J Pharm Pharmacol; 1996 Sep; 48(9):975-80. PubMed ID: 8910867
[TBL] [Abstract][Full Text] [Related]
12. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effect of YPE-01, a novel diarylheptanoid derivative, on dermal inflammation in mice.
Yamazaki R; Aiyama R; Matsuzaki T; Hashimoto S; Yokokura T
Inflamm Res; 1998 Apr; 47(4):182-6. PubMed ID: 9628261
[TBL] [Abstract][Full Text] [Related]
14. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.
Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP
Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196
[TBL] [Abstract][Full Text] [Related]
15. Variabilin: a dual inhibitor of human secretory and cytosolic phospholipase A2 with anti-inflammatory activity.
Escrig V; Ubeda A; Ferrandiz ML; Darias J; Sanchez JM; Alcaraz MJ; Paya M
J Pharmacol Exp Ther; 1997 Jul; 282(1):123-31. PubMed ID: 9223548
[TBL] [Abstract][Full Text] [Related]
16. Effects of naturally occurring dihydroflavonols from Inula viscosa on inflammation and enzymes involved in the arachidonic acid metabolism.
Hernández V; Recio MC; Máñez S; Giner RM; Ríos JL
Life Sci; 2007 Jul; 81(6):480-8. PubMed ID: 17658557
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2).
Glaser KB; Carlson RP; Sung A; Bauer J; Lock YW; Holloway D; Sturm R; Hartman D; Walter T; Woeppel S
Agents Actions; 1993; 39 Spec No():C30-2. PubMed ID: 8273577
[TBL] [Abstract][Full Text] [Related]
18. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
Garcia-Pastor P; Randazzo A; Gomez-Paloma L; Alcaraz MJ; Paya M
J Pharmacol Exp Ther; 1999 Apr; 289(1):166-72. PubMed ID: 10087000
[TBL] [Abstract][Full Text] [Related]
19. The antiinflammatory action of guanabenz is mediated through 5-lipoxygenase and cyclooxygenase inhibition.
Chang J; Blazek E; Skowronek M; Marinari L; Carlson RP
Eur J Pharmacol; 1987 Oct; 142(2):197-205. PubMed ID: 3121363
[TBL] [Abstract][Full Text] [Related]
20. 4-Alkoxybenzamidines as new potent phospholipase A2 inhibitors.
Aitdafoun M; Mounier C; Heymans F; Binisti C; Bon C; Godfroid JJ
Biochem Pharmacol; 1996 Mar; 51(6):737-42. PubMed ID: 8602868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
